TGFB1 and glioblastoma: Additionally, the GBM microenvironment includes glioma stem-like cells (GSCs) which evade immune therapies through multiple mechanisms including but not limited to the down regulation of MHC class I molecules, increasing Treg cells within the microenvironment, increasing TAM-produced TGF-β, and resulting down regulation of MHC II (40).